CRISPR co-inventor Doudna casts doubt on AI replacing humans in discovery

Jennifer Doudna, co-inventor of the CRISPR-Cas9 gene-editing technology and a Nobel laureate in chemistry, has expressed skepticism that AI can replace human effort in scientific discovery. According to a Bloomberg interview published on June 24, 2026, Doudna told the program 'The Circuit with Emily Chang' that she questions whether AI such as OpenAI's ChatGPT should receive credit for drug discovery, adding to the growing debate over AI's role in medical research and innovation.